Research publications

Evaluation of Hypofractionated Radiation Therapy Use and Patient-Reported Outcomes in Men With Nonmetastatic Prostate Cancer in Australia and New Zealand

Pryor DI, Martin JM, Millar JL, Day H, Ong WL, Skala M, FitzGerald LM, Hindson B, Higgs B, O'Callaghan ME, Syed F, Hayden AJ, Turner SL, Papa N

(2021), JAMA Netw Open, 4(11), e2129647

DOI: 10.1001/jamanetworkopen.2021.29647

Characterisation of a synthetic diamond detector for end-to-end dosimetry in stereotactic body radiotherapy and radiosurgery

Shaw M, Lye J, Alves A, Keehan S, Lehmann J, Hanlon M, Kenny J, Baines J, Porumb J, Geso M, Brown R

(2021), Physics and Imaging in Radiation Oncology, 20, 40-5

DOI: 10.1016/j.phro.2021.10.002

Curative Radiotherapy for Locally Advanced Scalp Squamous Cell Carcinoma

Xing D, Hettige S, Chee LYS, Nair R, Hegde R

(2021), Cureus, 13(10), e18514

DOI: 10.7759/cureus.18514

Successful Treatment of Malignant Priapism by Radiotherapy: Report of a Case, Review of the Literature, and Treatment Recommendations

Xing DT, Yilmaz H, Hettige S, Hegde R, Nair R

(2021), Cureus, 13(8), e17287

DOI: 10.7759/cureus.17287

Musculoskeletal Responses to Exercise Plus Nutrition in Men with Prostate Cancer on Androgen Deprivation: A 12-Month RCT

Dalla Via J, Owen PJ, Daly RM, Mundell NL, Livingston PM, Rantalainen T, Foulkes SJ, Millar JL, Murphy DG, Fraser SF

(2021), MED SCI SPORT EXER, 53(10), 2054-65

DOI: 10.1249/MSS.0000000000002682

Evolving Practice Pattern of Palliative Radiation Therapy for Bone Metastases from Lung Cancer in Australia

Ong WL, Ball DL, Milne RL, Foroudi F, Millar JL

(2021), CLIN ONCOL-UK, 33(12), e530-9

DOI: 10.1016/j.clon.2021.07.013

A novel surrogate for motion management in external beam radiotherapy of breast cancer patients

Damkjaer SMS, Jensen NKG, Fog LS, Josipovic M

(2021), Acta Oncol, 60(11), 1432-5

DOI: 10.1080/0284186X.2021.1949035

Temporal determinants of tumour response to neoadjuvant rectal radiotherapy

Koo K, Ward R, Smith RL, Ruben J, Carne PWG, Elsaleh H

(2021), PLoS one, 16(6), e0254018

DOI: 10.1371/journal.pone.0254018

Establishing a global quality of care benchmark report

Sampurno F, Cally J, Opie JL, Kannan A, Millar JL, Finelli A, Vickers AJ, Moore CM, Kowalski C, Foster C, Barocas DA, Galvin D, Van Basten JP, Gore JL, Ferencz J, Lawson KA, Ghani KR, Kwan L, Saarela O, Connor SE, Dieng S, Linsell S, Soeterik TFW, Villanti P, Litwin MS, Evans SM

(2021), HEALTH INFORM J, 27(2), 14604582211015704

DOI: 10.1177/14604582211015704

Radiation oncology training in Australia and New Zealand during and beyond the COVID-19 pandemic - lessons learnt and opportunities for improvement

Ong WL, Weerasinghe C

(2021), J MED IMAG RADIAT ON, 65(6), 826-8

DOI: 10.1111/1754-9485.13245

Patterns of care for prostate cancer treatment and improving outcomes - are national registries the answer?

O'Callaghan M, Papa N, Pase M, Frydenberg M, Mark S, Moretti K, Maqsood S, Smith D, Walker T, White C, Millar J, On behalf of the Prostate Cancer Outcomes Registry of Australia and New Zealand (PCOR-ANZ)

(2021), BJU Int, 128(Suppl 1), 6-8

DOI: 10.1111/bju.15366

A patient-centred approach to determine optimal supportive care across the cancer trajectory: a cross-sectional study

Turon H, Hill D, Watson R, Hobden B, Millar J, Sanson-Fisher R

(2021), Eur J Cancer Care, 30(5), e13455

DOI: 10.1111/ecc.13455

Measuring the dose in bone for spine stereotactic body radiotherapy,

Shaw M, Lye J, Alves A, Hanlon M, Lehmann J, Supple J, Porumb C, Williams I, Geso M, Brown R

(2021), PHYS MEDICA, 84, 265-73

DOI: 10.1016/j.ejmp.2021.03.011

Patterns of primary staging for newly diagnosed prostate cancer in the era of prostate specific membrane antigen positron emission tomography: A population-based analysis

Papa N, Perera M, Murphy DG, Lawrentschuk N, Evans M, Millar JL, Bolton D

(2021), J MED IMAG RADIAT ON, 65(6), 649-54

DOI: 10.1111/1754-9485.13162

Choosing wisely in radiation therapy for breast cancer: Time lag in adoption of hypofractionated radiation therapy in Victoria

Ong WL, Khor R, Chao M, Milne RL, Millar J, Foroudi F

(2021), J MED IMAG RADIAT ON, 65(2), 224-32

DOI: 10.1111/1754-9485.13155

Dose-Response and Normal Tissue Complication Probabilities after Proton Therapy for Choroidal Melanoma

Espensen CA, Kilgaard JF, Appelt AL, Fog LS, Herault J, Maschi C, Caujolle JP, Thariat J

(2021), Ophthalmology, 128(1), 152-61

DOI: 10.1016/j.ophtha.2020.06.030

HDR brachytherapy well chamber calibration and stability evaluated over twenty years of clinical use

Keehan S, Smith RL, Butler D

(2021), Brachytherapy, 20(1), 257-64

DOI: 10.1016/j.brachy.2020.08.017

Trends in Conservative Management for Low-risk Prostate Cancer in a Population-based Cohort of Australian Men Diagnosed Between 2009 and 2016

Ong WL, Evans SM, Evans M, Tacey M, Dodds L, Kearns P, Milne RL, Foroudi F, Millar J

(2021), Eur Urol Oncol, 4(2), 319-22

DOI: 10.1016/j.euo.2019.04.006

Response to ventilator adjustments for predicting acute respiratory distress mortality. Driving pressure versus oxygenation

Yehya N, Hodgson CL, Amato MBP, Richard JC, Brochard LJ, Mercat A, Goligher EC

(2021), Ann Am Thorac Soc, 18(5), 857-64

DOI: 10.1513/AnnalsATS.202007-862OC

Design and Rationale of a Prospective International Follow-Up Study on Intensive Care Survivors of COVID-19: The Long-Term Impact in Intensive Care Survivors of Coronavirus Disease-19-AFTERCOR

Wildi K, Li Bassi G, Barnett A, Panigada M, Colombo SM, Bandera A, Muscatello A, McNicholas B, Laffey JG, Battaglini D, Robba C, Torres A, Motos A, Luna CM, Rainieri F, Hodgson C, Burrell AJC, Buscher H, Dalton H, Cho SM, Choi HA, Thomson D, Suen J, Fraser JF

(2021), FRONT MED-LAUSANNE, 8, 738086

DOI: 10.3389/fmed.2021.738086

Publication Details